Polatuzumab Vedotin Plus Venetoclax with Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Primary Efficacy Analysis of a Phase Ib/II Study
暂无分享,去创建一个
C. Flowers | P. Marlton | T. Phillips | G. Gritti | J. Seymour | P. Corradini | R. Bannerji | L. Musick | C. Arthur | J. Hirata | S. Yuen | A. Johnston | Brandon Croft | Sourish Saha